Sonendo, Inc.
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Sonendo, Inc. is a commercial-stage medical technology company headquartered in Laguna Hills, California, focused on the development, manufacturing, and commercialization of innovative devices for root canal therapy and treatment of tooth decay. Founded in 2006, Sonendo's core product portfolio centers on the GentleWave® System, a patented technology platform that employs multisonic ultrasonic cleaning, broad-spectrum acoustic energy, and advanced fluid dynamics to clean and disinfect the microscopic spaces within teeth during root canal procedures, without the need to remove tooth structure. Alongside the GentleWave System, the company offers related consumables such as the CleanFlow® instrument designed to minimize tooth damage, Sonendo-branded liquid solutions including ethylenediaminetetraacetic acid (EDTA) for root canal disinfection, and SoundSeal materials to create sealing platforms on tooth crowns. Sonendo also provides the TDO® Software for dental practice management, supporting integrated digital workflows for endodontists. Geographically, Sonendo operates primarily in the United States and Canada, targeting dental practices specializing in endodontics and restorative dentistry. The company markets the GentleWave System through a direct sales force and supplements this with clinical education and reimbursement support services to facilitate adoption and optimal use of its technology. Sonendo generates revenue through system sales, leasing arrangements, consumables, and maintenance service contracts. In the past 1-2 years, Sonendo made notable operational and financial progress, including a $5.0 million private placement of common stock in early 2025 to strengthen liquidity. The company has improved its gross margins substantially, reaching approximately 44-46% in 2025, and reduced operating losses significantly by focusing on cost-efficient sales strategies and higher utilization of the GentleWave console and procedure instruments. Sonendo reaffirmed its 2025 revenue guidance of $31-$32 million and anticipates positive adjusted EBITDA by 2028. Additionally, Sonendo executed an asset purchase agreement to acquire assets from Biolase, enhancing its strategic position and product offerings in the dental technology market. These steps align with its strategic focus on operational excellence and sustainable, long-term growth within the dental healthcare industry. Overall, Sonendo is positioned as a leader in endodontic innovation with a mission to save teeth from decay through less invasive, highly effective treatment technologies supported by comprehensive service and software solutions. This description incorporates the company's product specifics and recent strategic and financial developments up to late 2025.
Sonendo, Inc. on Path to Breakeven in the Second Half of 2026
Sonendo (NYSE:SONX) Shares Up 475% – Here’s Why
Sonendo (NYSE:SONX) Trading Up 3.5% – Time to Buy?
Sonendo (NYSE:SONX) Trading Up 3.8% – Here’s Why
Sonendo Strengthens Leadership Team With Promotion of John McGaugh to Chief Operating Officer
Sonendo, Inc. Reports Second Quarter 2025 Financial Results and Reaffirms Financial Guidance
Sonendo, Inc. Reports First Quarter 2025 Financial Results and Issues Financial Guidance
Sonendo, Inc. Announces $5.0 Million Private Placement
Sonendo Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
Sonendo, Inc. to Release Third Quarter 2024 Financial Results and Postpone Conference Call on November 12, 2024
Sonendo, Inc. (SONX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Sonendo Launches ProControlTM for the GentleWave® G4 System
Sonendo, Inc. Announces Preliminary Third Quarter 2024 Financial Results
Here's Why Sonendo (SONX) Is a Great 'Buy the Bottom' Stock Now
Sonendo, Inc. (SONX) Q2 2024 Earnings Call Transcript
Sonendo, Inc. (SONX) Reports Q2 Loss, Tops Revenue Estimates
Sonendo Strengthens Leadership With Key Strategic Appointments
Sonendo, Inc. (SONX) Q1 2024 Earnings Call Transcript
Sonendo, Inc. (SONX) Reports Q1 Loss, Tops Revenue Estimates
Sonendo, Inc. to Report First Quarter 2024 Financial Results on May 8, 2024